Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Licenses Rosetta Inpharmatics siRNA Informatics Technology

NEW YORK, May 24 (GenomeWeb News) - Sigma-Aldrich has gained an exclusive license to Rosetta Inpharmatics' bioinformatics design tools for siRNA research and development purposes, Rosetta said today.

 

Sigma- Aldrich said it plans to use Rosetta' design technology to launch human and model organism siRNA whole-genome libraries, to deliver siRNA panels targeted to specific gene families, and to provide access to single-target pre-designed siRNAs through an enhanced Web interface on its website.

 

Rosetta is a wholly owned subsidiary of Merck.

 

Financial details were not discussed.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.